Literature DB >> 5549972

Fibrinogen degradation products in serum and urine of patients with systemic lupus erythematosus. Relation to renal disease and pathogenetic mechanism.

B R Kanyerezi, S K Lwanga, K J Block.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5549972     DOI： 10.1002/art.1780140213

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  6 in total

1.  Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes.

Authors:  H Rothberger; T S Zimmerman; H L Spiegelberg; J H Vaughan
Journal:  J Clin Invest       Date:  1977-03       Impact factor: 14.808

2.  Fibrinopeptide A in plasma of normal subjects and patients with disseminated intravascular coagulation and systemic lupus erythematosus.

Authors:  M Cronlund; J Hardin; J Burton; L Lee; E Haber; K J Bloch
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

3.  Fibrin degradation products in rheumatoid arthritis.

Authors:  R M Bennett; A C Eddie-Quartey; P J Holt
Journal:  Ann Rheum Dis       Date:  1972-09       Impact factor: 19.103

Review 4.  Relationships among the complement, kinin, coagulation, and fibrinolytic systems.

Authors:  J S Sundsmo; D S Fair
Journal:  Springer Semin Immunopathol       Date:  1983

5.  [Pathogenesis of uremic pneumonitis (author's transl)].

Authors:  U Bleyl; C Werner; C M Büsing
Journal:  Klin Wochenschr       Date:  1978-02-01

6.  Increased production and expression of tissue thromboplastin-like procoagulant activity in vitro by allogeneically stimulated human leukocytes.

Authors:  H Rothberger; T S Zimmerman; J H Vaughan
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.